Concepedia

Joy Drobnick

JD

Statistics

Publications

11

Citations

559

H-Index

11

Active since

2014

Affiliations

WuXi AppTec (China)(Current)

Health and Functional Exposomics

Charles River Laboratories (United Kingdom)

Shanghai Zhangjiang Laboratory

Joy Drobnick is an author at WuXi AppTec (China) specializing in medicinal chemistry, drug discovery, and pharmacology.

Publications per year

2014–2020

11

Publications

11

Discovery of Clinical Development Candidate GDC-0084, a Brain Penetrant Inhibitor of PI3K and mTOR

Timothy P. Heffron, Chudi Ndubaku, Laurent Salphati et al. · ACS Medicinal Chemistry Letters · 2016 · 105 citations · Full text

, , +16

Discovery of Small-Molecule Inhibitors of Ubiquitin Specific Protease 7 (USP7) Using Integrated NMR and in Silico Techniques

Paola Di Lello, Richard Pastor, Jeremy Murray et al. · Journal of Medicinal Chemistry · 2017 · 89 citations · Full text

, , +17

Design of Selective PAK1 Inhibitor G-5555: Improving Properties by Employing an Unorthodox Low-p <i>K</i> <sub>a</sub> Polar Moiety

Chudi Ndubaku, James J. Crawford, Joy Drobnick et al. · ACS Medicinal Chemistry Letters · 2015 · 86 citations · Full text

, , +10

Chemically Diverse Group I p21-Activated Kinase (PAK) Inhibitors Impart Acute Cardiovascular Toxicity with a Narrow Therapeutic Window

Joachim Rudolph, Lesley Murray, Chudi Ndubaku et al. · Journal of Medicinal Chemistry · 2016 · 77 citations · Full text

, , +13

Structure-Based Design of GNE-495, a Potent and Selective MAP4K4 Inhibitor with Efficacy in Retinal Angiogenesis

Chudi Ndubaku, Terry D. Crawford, Huifen Chen et al. · ACS Medicinal Chemistry Letters · 2015 · 46 citations · Full text

, , +13

1–5 of 11